Charter Communications ( CHTR) emerged as the most shorted S&P 500 ( SP500) stock as a percentage of float in November, ...
Asianet Newsable on MSN
Moderna and Super Micro top S&P 500 short interest list — are they ripe for a squeeze?
Investors remain divided on Moderna and Super Micro as heavy short interest reflects skepticism, yet recent catalysts suggest ...
Moderna Inc. (NASDAQ:MRNA) is one of the high short interest stocks to buy right now. On November 20, Moderna announced that ...
Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to five injectable ...
The Trump administration in May canceled a $700 million contract with Moderna to develop a human bird flu vaccine. Health ...
The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine ...
Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...
The Food and Drug Administration is investigating whether COVID-19 vaccines caused deaths in adults, as part of a safety ...
An internal memo written by the Food and Drug Administration’s top vaccine regulator offers a concerning glimpse into the ...
A backlash against pandemic-era restrictions, online misinformation, and a lack of resources for healthcare have contributed ...
The U.S. health regulator is investigating deaths potentially related to COVID-19 vaccines across multiple age groups as part ...
Opinion
1dOpinion
Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons
The vaccines received Emergency Use Authorization (EUA) in December 2020 after only 20 weeks of testing, authors write. The highly atypical trial protocol was part of a “declared health emergency,” as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback